Skip to main content Scroll Top

Actualités

  • Accueil
  • Alzheimer
  • A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance
Posts les plus vus
Clear Filters
La lumière peut-elle soigner le cerveau ? REGEnLIFE explore la photobiomodulation pour lutter contre la maladie d’Alzheimer
The Neuroprotective Effect Of A New Photobiomodulation Technique On Aβ25-35 Peptide-Induced Toxicity Dramatically Impact Gut Microbiota Dysbiosis
The Neuroprotective Effect Of A New Photobiomodulation Technique On Aβ25-35 Peptide-Induced Toxicity Dramatically Impact Gut Microbiota Dysbiosis

A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance

JAD Journal of Alzheimer's Disease

Blivet G, Relano-Gines A, Wachtel M, Touchon J.

J Alzheimers Dis. 2022;90(2):811-822. doi: 10.3233/JAD-220467.

PMID: 36189591 Clinical Trial.

Partagez cet article